IKBKG and obesity disorder: NEMOSMCiKO/ApoE−/− and ApoE−/− mice showed similar body weight and serum levels of cholesterol and triglycerides after HFD treatment (Fig. 1a–c), indicating that SMC-specific deletion of NEMO did not affect HFD-induced obesity or basic lipid metabolism.